PKRP与TUVP治疗良性前列腺增生症(BPH)的对比研究

Study of PKRP and TUVP in treatment of benign prostatic hyperplasia(BPH)

目的对比分析经尿道等离子电切术(PKRP)与传统电切术(TUVP)治疗良性前列腺增生症(BPH)的疗效。方法 80例行手术治疗的BPH患者中PKRP治疗的40例患者设立为观察组,另外选择同期行TUVP治疗的40例患者设立为对照组,比较两组患者手术时间及术中出血量、住院时间,两组患者术前术后IPSS、最大尿流率(Qmax)的变化以及两组患者术后并发症发生率。结果观察组的手术时间、住院时间分别与对照组比较,差异无统计学意义(P>0.05),观察组的术中出血量明显少于对照组(P<0.01)。术后观察组Qmax与对照组比较明显升高,观察组的IPSS术后较对照组明显降低,组间比较差异有统计学意义(P<0.05),观察组术后无一例发生电切综合症,其并发症发生率达5%(2/40),对照组术后并发症发生率达25%(10/40),两组并发症发生率比较,差异有统计学意义(P<0.05)。结论经尿道等离子电切术(PKRP)较传统电切术(TUVP)治疗良性前列腺增生症出血少、并发症少、术后能明显改善患者的临床症状,值得推广和应用。

Objective To analyze PKRP with traditional electrosurgical excision procedure （TUVP） treatment of benign prostatic hyperplasia（BPH） in effect, seeks to provide effective reference for the treatment of BPH. Methods A total of 80 patients underwent surgery for BPH in the plasma of patients undergoing PKRP treatment of 40 patients with BPH were set up for the observation group, choose another concomitant TUVP treatment of 40 patients with BPH were estab lished for the control group, two groups were compared operative time and blood loss, hospital stay, two groups of pa tients before and after surgery IPSS, maximum urinary flow rate （Qmax） changes in the incidence of postoperative com plications in both groups of patients. Results The patient＇s surgery, hospitalization time respectively compared with the control group, the difference was not statistically significant （P〉0.05）, blood loss in the observation group was signifi cantly less than the control group（P〈 0.01 ）. Qmax postoperative patients and the control group was significantly higher than the control group of patients with IPSS groups were observed significantly lower（P〈0.05） between the two groups, the observation group was no case electricity occurs cut syndrome, its complication rate of 5%（2/40）, the control group postoperative complication rate of 25% （10/40） , the incidence of complications between the two groups, the difference was statistically significant （P〈 0.05）. Conclusion PKRP treatment of benign prostatic hyperplasia with less bleeding, fewer complications than TUVP, can significantly improve the clinical symptoms, should be promoted and applied.